Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Malignancy, × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1712 Breast Neoplasms 1028 Carcinoma, Non-Small-Cell Lung 1018 Leukemia, Myeloid, Acute 814 Neoplasm Metastasis 747 Melanoma 656 Lymphoma 625 Multiple Myeloma 616 Colorectal Neoplasms 615 Ovarian Neoplasms 571 Pancreatic Neoplasms 561 Lymphoma, Non-Hodgkin 560 Prostatic Neoplasms 550 Recurrence 543 Precursor Cell Lymphoblastic Leukemia-Lymphoma 488 Leukemia, Lymphocytic, Chronic, B-Cell 468 Lung Neoplasms 467 Glioblastoma 452 Leukemia 418 Lymphoma, Large B-Cell, Diffuse 371 Brain Neoplasms 357 Lymphoma, Follicular 346 Carcinoma, Renal Cell 326 Myelodysplastic Syndromes 322 Stomach Neoplasms 321 Squamous Cell Carcinoma of Head and Neck 318 Carcinoma, Hepatocellular 316 Advanced Solid Tumors 297 Glioma 289 Lymphoma, Mantle-Cell 288

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01895946 2016-05-25

OAK

AstraZeneca

Phase 1 Completed

33 enrolled 14 charts

Advanced Solid Malignancy,

Data powered by HemOnc (CC BY 4.0) Colophon ⚡